Increlex Injection, Solution
Product Images NDC 15054-1040

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Increlex (NDC 15054-1040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ipsen Biopharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Increlex 01)

A line graph depicting mean total IGF-1 (ng/mL) levels over time (hours) for two different doses of Increlex (mecasermin) at 0.12 mg/kg and 0.06 mg/kg. The y-axis shows IGF-1 concentration, and the x-axis represents time in hours. Data points are connected to show serum IGF-1 level trends following dosing.*

FDA Label Image

Figure 1 (Increlex 02)

An instructional illustration showing a hand removing a protective cap from a vial and another hand holding the vial by its rubber top, demonstrating the proper way to access the subcutaneous injection solution.*

FDA Label Image

Figure 2 (Increlex 03)

An instructional illustration showing hands holding and preparing a vial for injection, demonstrating the steps to administer a subcutaneous injection using the vial's rubber stopper.*

FDA Label Image

Figure 3 (Increlex 04)

An instructional illustration showing a hand preparing an injection vial with a syringe, demonstrating the process of drawing medication from the vial. The image depicts the syringe needle inserted into the vial stopper and an arrow indicating upward movement of the syringe plunger.*

FDA Label Image

Figure 4 (Increlex 05)

An instructional illustration depicting a person's hands preparing an injection. One hand holds a vial upside down, while the other hand pulls liquid into a syringe, indicating the preparation of a subcutaneous injection.*

FDA Label Image

Figures 5 And 6 (Increlex 06)

Instructional illustration showing two hand positions for using a syringe with a vial or injection device. The left image shows one hand holding the vial and the other drawing solution into the syringe. The right image depicts one hand holding the syringe and the other adjusting or removing the needle cap with an arrow indicating direction.*

FDA Label Image

Figure 7 (Increlex 07)

An instructional diagram illustrating a hand holding a syringe with a vial attached, demonstrating the preparation or drawing of a solution for injection.*

FDA Label Image

Figure 8 (Increlex 08)

An instructional illustration showing a hand holding a syringe with the needle pointing upwards, typically depicting preparation or administration of an injection. No text or additional details are present.*

FDA Label Image

Figure (Increlex 09)

An instructional illustration showing two views, front and back, of a human torso with highlighted areas on the upper arms indicating the recommended subcutaneous injection sites for administering medication.*

FDA Label Image

Figure (Increlex 10)

An instructional illustration showing three views of a human torso highlighting areas for subcutaneous injection. The dark circular marks indicate preferred injection sites: the outer upper arms, the abdomen, and the anterior thighs. This diagram aids in visualizing appropriate injection locations for subcutaneous administration.*

FDA Label Image

Figure (Increlex 11)

An illustration showing how to perform a subcutaneous injection on the thigh. The graphic depicts a simplified human figure with arrows pointing to the injection site on the outer thigh area, indicating the proper location for administration.*

FDA Label Image

Figure (Increlex 12)

An illustration showing two anatomical diagrams of the human torso, focusing on the abdominal area. The diagrams indicate injection sites marked by gray dots on the right and left sides of the abdomen, highlighting recommended subcutaneous injection locations.*

FDA Label Image

Figure A (Increlex 13)

An instructional illustration showing a hand holding a syringe with the needle pointed downward toward the skin, demonstrating the subcutaneous injection technique with a downward arrow indicating the direction of needle insertion.*

FDA Label Image

Figure B (Increlex 14)

An instructional line drawing showing a hand holding and peeling back the corner of a square adhesive patch or wipe, likely related to a step for administration or preparation of the product Increlex (mecasermin) injection.*

FDA Label Image

Principal Display Panel (40 mg Vial Carton)

Carton packaging label for Increlex (mecasermin) injection, 40 mg/4 mL (10 mg/mL) subcutaneous injection by Ipsen Biopharmaceuticals, Inc. The label includes dosage strength, manufacturer information, a list of inactive ingredients, storage instructions, and a barcode with NDC 15054-1040-5. The product is marked Rx only and for subcutaneous use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.